老年早期乳腺癌幸存者个体化监测性乳腺X线摄影:多学科专家小组与国际老年肿瘤学会共识声明
该共识针对75岁及以上早期乳腺癌幸存者的监测性乳腺X线摄影提出个体化决策框架。基于文献综述与多学科专家迭代共识,建议根据预期寿命分层:预期寿命不足5年者停止常规乳腺X线摄影(包括高危癌症史者),5至10年者考虑停止,超过10年者继续。鼓励结合获益与危害及患者偏好进行共享决策,并继续临床乳腺检查及诊断性乳腺X线摄影评估症状。
要点
- 预期寿命不足5年的乳腺癌幸存者(含高危癌症史)建议停止常规监测性乳腺X线摄影。
- 预期寿命5至10年者可考虑停止乳腺X线摄影,超过10年者建议继续。
- 应个体化共享决策,继续临床乳腺检查及诊断性乳腺X线摄影评估症状。
核心结论
- 对于75岁及以上早期乳腺癌幸存者,监测性乳腺X线摄影应根据预期寿命和患者偏好个体化决策。
- 预期寿命不足5年者建议停止常规乳腺X线摄影,5至10年者可考虑停止,超过10年者建议继续。
研究设计与样本
- 文献综述结合多学科专家小组迭代共识方法,并经临床医生焦点小组输入和国际老年肿瘤学会审阅。
主要发现
- 文献综述显示大多数老年乳腺癌幸存者同侧和对侧乳腺事件风险较低,并总结了乳腺X线摄影的获益与危害。
- 共识强调根据患者乳腺事件风险、年龄、预期寿命和个人偏好进行个体化决策。
关键数值与推荐
- 预期寿命不足5年:建议停止常规乳腺X线摄影,包括有高危癌症史者。
- 预期寿命5至10年:考虑停止乳腺X线摄影。
- 预期寿命超过10年:继续乳腺X线摄影。
临床怎么用
- 临床中应基于预期寿命分层与患者共享决策,讨论监测性乳腺X线摄影的获益与危害。
- 继续临床乳腺检查及诊断性乳腺X线摄影以评估临床发现和症状,并向患者保证这些实践将持续。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: There is currently no guidance on how to approach surveillance mammography for older breast cancer survivors, particularly when life expectancy is limited. OBJECTIVE: To develop expert consensus guidelines that facilitate tailored decision-making for routine surveillance mammography for breast cancer survivors 75 years or older. EVIDENCE: After a literature review of the risk of ipsilateral and contralateral breast cancer events among breast cancer survivors and the harms and benefits associated with mammography, a multidisciplinary expert panel was convened to develop consensus guidelines on surveillance mammography for breast cancer survivors 75 years or older. Using an iterative consensus-based approach, input from clinician focus groups, and critical review by the International Society for Geriatric Oncology, the guidelines were refined and finalized. FINDINGS: The literature review established a low risk for ipsilateral and contralateral breast cancer events in most older breast cancer survivors and summarized the benefits and harms associated with mammography. Draft mammography guidelines were iteratively evaluated by the expert panel and clinician focus groups, emphasizing a patient's risk for in-breast cancer events, age, life expectancy, and personal preferences. The final consensus guidelines recommend discontinuation of routine mammography for all breast cancer survivors when life expectancy is less than 5 years, including those with a history of high-risk cancers; consideration to discontinue mammography when life expectancy is 5 to 10 years; and continuation of mammography when life expectancy is more than 10 years. Individualized, shared decision-making is encouraged to optimally tailor recommendations after weighing the benefits and harms associated with surveillance mammography and patient preferences. The panel also recommends ongoing clinical breast examinations and diagnostic mammography to evaluate clinical findings and symptoms, with reassurance for patients that these practices will continue. CONCLUSIONS AND RELEVANCE: It is anticipated that these expert guidelines will enhance clinical practice by providing a framework for individualized discussions, facilitating shared decision-making regarding surveillance mammography for breast cancer survivors 75 years or older.
引用
- Freedman RA, Minami CA, Winer EP, et al. Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. 2021. PMID: 33507222. doi:10.1001/jamaoncol.2020.7582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。